SEC Contract Filing

Filing Date: 2024-08-01

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>qure-20240630xex10d2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge 10.6.125.0--><!--Created on: 8/1/2024 11:13:36 AM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;font-style:italic;font-weight:bold;">Exhibit 10.2</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;font-style:italic;font-weight:bold;">Execution Version</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><u style="font-size:12pt;font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">[***] CERTAIN INFORMATION HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10)(IV) FROM THIS DOCUMENT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">CONSENT AND AMENDMENT NO. 2 TO </b><b style="font-size:12pt;font-weight:bold;"><br></b><b style="font-size:12pt;font-weight:bold;">THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">This </font><b style="font-size:12pt;font-weight:bold;">CONSENT AND AMENDMENT NO. 2 TO THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT </b><font style="font-size:12pt;">(this &#8220;</font><b style="font-size:12pt;font-weight:bold;">Consent and Amendment</b><font style="font-size:12pt;">&#8221;), is dated as of June 28, 2024 and is entered into by and among (a) (i) </font><b style="font-size:12pt;font-weight:bold;">UNIQURE BIOPHARMA B.V.</b><font style="font-size:12pt;">, a private limited liability company incorporated and existing under the laws of the Netherlands, having its corporate seat at Amsterdam, the Netherlands and registered at the trade register of the Chamber of Commerce for Amsterdam under number 34275365 (&#8220;</font><b style="font-size:12pt;font-weight:bold;">uniQure Bio</b><font style="font-size:12pt;">&#8221;), (ii) </font><b style="font-size:12pt;font-weight:bold;">UNIQURE, INC.</b><font style="font-size:12pt;">, a Delaware corporation (&#8220;</font><b style="font-size:12pt;font-weight:bold;">US Borrower</b><font style="font-size:12pt;">&#8221; and together with uniQure Bio hereinafter collectively referred to as &#8220;</font><b style="font-size:12pt;font-weight:bold;">Borrower</b><font style="font-size:12pt;">&#8221;), (iii) </font><b style="font-size:12pt;font-weight:bold;">UNIQURE IP B.V.</b><font style="font-size:12pt;">, a private limited liability company incorporated and existing under the laws of the Netherlands, having its corporate seat at Amsterdam, the Netherlands and registered at the trade register of the Chamber of Commerce for Amsterdam under number 34275369 (&#8220;</font><b style="font-size:12pt;font-weight:bold;">uniQure IP</b><font style="font-size:12pt;">&#8221;), and (iv) </font><b style="font-size:12pt;font-weight:bold;">UNIQURE N.V.</b><font style="font-size:12pt;"> (formerly uniQure B.V.), a public limited company incorporated and existing under the laws of the Netherlands, having its corporate seat at Amsterdam, the Netherlands and registered at the trade register of the Chamber of Commerce for Amsterdam under number 54385229 (&#8220;</font><b style="font-size:12pt;font-weight:bold;">uniQure Holdings</b><font style="font-size:12pt;">&#8221; and, together with Borrower and uniQure IP, the &#8220;</font><b style="font-size:12pt;font-weight:bold;">Obligors</b><font style="font-size:12pt;">&#8221;), (b) </font><b style="font-size:12pt;font-weight:bold;">HERCULES CAPITAL, INC.</b><font style="font-size:12pt;">, a Maryland corporation in its capacity as administrative agent and collateral agent for itself and the Lender (as defined herein) (in such capacity, &#8220;</font><b style="font-size:12pt;font-weight:bold;">Agent</b><font style="font-size:12pt;">&#8221;), and (c) the several banks and other financial institutions or entities from time to time parties to the Loan Agreement (collectively, referred to as &#8220;</font><b style="font-size:12pt;font-weight:bold;">Lender</b><font style="font-size:12pt;">&#8221;). &#160;Capitalized terms used herein without definition shall have the same meanings given them in the Amended Loan Agreement (as defined below).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">RECITALS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:bold;">A.</b></font><b style="font-size:12pt;font-weight:bold;">WHEREAS</b><font style="font-size:12pt;">, Obligors, Agent and Lender have entered into that certain Third Amended and Restated Loan and Security Agreement, dated as of December 15, 2021, as amended by Amendment No. 1 to Third Amended and Restated Loan and Security Agreement, dated as of May 12, 20